Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Abraham A Ali"'
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263667 (2022)
BackgroundSince COVID-19 has been declared as a global pandemic, South Nations, Nationalities People's Region, Ethiopia, has been responding by establishing strong structure. The response against the disease requires consolidated efforts, However, th
Externí odkaz:
https://doaj.org/article/9358acde6baf47e492539510773faf75
Autor:
Yauwan Tobing Lukiyono, Abraham Ahmad Ali Firdaus, Salfa Salsabilah Zain, Anis Hanifa Rahmawati, Nur Zulviah
Publikováno v:
Jurnal Soeropati, Vol 5, Iss 1, Pp 65-71 (2022)
Hypertension is a condition in which a person experiences an increase in systolic blood pressure of more or equal to 140 mmHg and diastolic blood pressure of more or equal to 90 mmHg. Currently, the estimated number of cases of hypertension in Indone
Externí odkaz:
https://doaj.org/article/e9639f381a25460fb1b68040a12653df
Publikováno v:
Qanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya, Vol 2, Iss 01 (2018)
Pesantren as dormitory-based educational institutions familiarize their students with sleep patterns and certain activities, including sports that increase reaction time. This study aims to prove the relationship between sleep patterns and reaction t
Externí odkaz:
https://doaj.org/article/cddaa11249204da88915f78b98fece47
Autor:
Moch Sahri, Gilang Nugraha, Abraham Ahmad Ali Firdaus, Rizka Wahyu Safitri, Nur Muhamad Nuzulul Syufi
Publikováno v:
JURNAL KREATIVITAS PENGABDIAN KEPADA MASYARAKAT (PKM). 4:1338-1342
Berdasarkan penelitain sebelumnya diketahui bahwa lokasi kegiatan pengabdian masyarakat, didapatkan hasil pengukuran kadar uap benzene dilingkungan kerja dengan kisaran 0,3-1,5 ppm. Anemia aplastik yang disebabkan oleh penekanan sumsum tulang adalah
Publikováno v:
Suplemento 2. 129
Introduction: Heart failure is the most common cause of death. About 20 %-40 % of heart failure patients’ have depressive disorders. Improvements in patients’ quality of life could give an effect on the progression of cardiovascular disease. This
Publikováno v:
Medical and Health Science Journal. 2
Latar Belakang: Sindrom Koroner Akut (SKA) memiliki variabilitas yang cukup besar dalam risiko outcome dan mortalitas. Major Adverse Cardiovascular Events (MACE) adalah hasil akhir atau end stage SKA yang didefinisikan sebagai aritmia, syok kardiogen
Publikováno v:
Qanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya, Vol 2, Iss 01 (2018)
Pesantren as dormitory-based educational institutions familiarize their students with sleep patterns and certain activities, including sports that increase reaction time. This study aims to prove the relationship between sleep patterns and reaction t
Publikováno v:
The Indonesian Journal of Health Science; Vol 10, No 2 (2018): The Indonesian Journal Of Health Science; 26-35
Sindroma Koroner Akut (SKA) merupakan kondisi yang mengancam nyawa, oleh karena itu pasien SKA beresiko mengalami mortalitas dan membutuhkan prediksi awal berupa marker jantung salah satunya adalah CK-MB. Pemeriksaan CK-MB dengan hasil yang meningkat
Autor:
Abera A, Tegally H, Tasew G, Wilkinson E, Ali A, Regasa F, Bitew M, Chabuka L, Mwanyika G, Tshiabuila D, Giandhari J, Pillay S, Poogavanan J, Moir M, Kraemer MUG, Khan K, Huber C, Tollera G, de Wit TFR, Baxter C, Lessells R, Wolday D, Beyene D, de Oliveira T
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 Jul 10. Date of Electronic Publication: 2024 Jul 10.
Autor:
Ali A; Department of Pulmonary Medicine, Fundación Neumológica Colombiana, Bogotá, Colombia., García E; Department of allergology, Fundación Santa Fe de Bogotá, Otorhinolaryngology Medical-Surgical Unit (UNIMEQ-ORL), Bogotá, Colombia., Torres-Duque CA; CINEUMO, Research Center, Fundación Neumológica Colombiana, Bogotá, Colombia., Rey D; Department of Pulmonary Medicine, Fundación Cardiovascular de Colombia, Hospital Internacional de Colombia, Bucaramanga, Colombia., Botero L; Sanofi, Bogotá, Colombia., Saenz S, Avila MP; Sanofi, Bogotá, Colombia., Mazo E; Sanofi, Bogotá, Colombia., Londoño S; Sanofi, Bogotá, Colombia.
Publikováno v:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Mar; Vol. 24 (3), pp. 361-374. Date of Electronic Publication: 2024 Feb 01.